Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Toxicol Environ Health A ; 79(21): 998-1007, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27710705

RESUMEN

Based on the antioxidant properties of pomegranate, this study was designed to investigate the effects of pomegranate peel extract on damage associated with hypertension and aging in a spontaneously hypertensive rat (SHR) model. The influence of pomegranate consumption was examined on systolic blood pressure (SBP), angiotensin-converting enzyme (ACE) coronary activity, oxidative stress, and vascular morphology. Four- or 28-wk-old SHR model rats were treated for 30 d, with terminal experimental animal age being 8 and 32 wk, respectively, with either pomegranate extract (SHR-PG) or filtered water (SHR). Data showed significant reduction in SBP and coronary ACE activity in both age groups. The levels of superoxide anion, a measure of oxidative stress, were significantly lower in animals in the SHR-PG group compared to SHR alone. Coronary morphology demonstrated total increases in vascular wall areas were in the SHR group, and pomegranate peel extract diminished this effect. Pomegranate peel extract consumption conferred protection against hypertension in the SHR model. This finding was demonstrated by marked reduction in coronary ACE activity, oxidative stress, and vascular remodelling. In addition, treatment was able to reduce SBP in both groups. Evidence indicates that the use of pomegranate peel extract may prove beneficial in alleviating coronary heart disease.


Asunto(s)
Antioxidantes/farmacología , Hipertensión/fisiopatología , Lythraceae/química , Estrés Oxidativo/efectos de los fármacos , Peptidil-Dipeptidasa A/metabolismo , Extractos Vegetales/farmacología , Remodelación Vascular , Animales , Femenino , Frutas/química , Ratas , Ratas Endogámicas SHR
2.
Can J Physiol Pharmacol ; 90(1): 75-82, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22217235

RESUMEN

Several studies have demonstrated that gonadal hormones show significant effects on the brain and signaling pathways of effector organs/cells that respond to neurotransmitters. Since little information is available concerning the impact of male and female gonadal hormones on the renal and peripheral sympathetic system, the objective of this study was to further assess whether and how the renal content and plasma concentration of catecholamines are influenced by gender and the estrous cycle in rats. To achieve this, males Wistar rats were divided into 4 groups: (i) sham (i.e., control), (ii) gonadectomized, (iii) gonadectomized and nandrolone decanoate replacement at physiological levels or (iv) gonadectomized and nandrolone decanoate replacement at high levels. Female Wistar rats were divided into 6 groups: (i) ovariectomized (OVX), (ii) estrogen replacement at physiological levels and (iii) estrogen replacement at at high levels, (iv) progesterone replacement at physiological levels and (v) progesterone replacement at at high levels, and (vi) sham. The sham group was subdivided into four subgroups: (i) proestrus, (ii) estrus, (iii) metaestrus, and (iv) diestrus. Ten days after surgery, the animals were sacrificed and their plasma and renal catecholamine levels measured for intergroup comparisons. Gonadectomy led to an increase in the plasma catecholamine concentration in females, as well as in the renal catecholamine content of both male and female rats. Gonadectomized males also showed a lower level of plasma catecholamine than the controls. The urinary flow, and the fractional excretion of sodium and chloride were significantly increased in gonadectomized males and in the OVX group when compared with their respective sham groups.


Asunto(s)
Catecolaminas/sangre , Catecolaminas/metabolismo , Ciclo Estral/sangre , Ciclo Estral/metabolismo , Riñón/metabolismo , Animales , Cloruros/orina , Relación Dosis-Respuesta a Droga , Estradiol/administración & dosificación , Estradiol/farmacología , Femenino , Hormonas Gonadales/administración & dosificación , Hormonas Gonadales/farmacología , Riñón/efectos de los fármacos , Riñón/fisiopatología , Masculino , Nandrolona/administración & dosificación , Nandrolona/análogos & derivados , Nandrolona/farmacología , Nandrolona Decanoato , Orquiectomía/métodos , Orquiectomía/estadística & datos numéricos , Ovariectomía/métodos , Ovariectomía/estadística & datos numéricos , Progesterona/administración & dosificación , Progesterona/farmacología , Ratas , Ratas Wistar , Caracteres Sexuales , Sodio/orina , Micción/efectos de los fármacos , Micción/fisiología
3.
Curr Pharm Des ; 26(30): 3684-3699, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32250215

RESUMEN

BACKGROUND: Punica granatum L. is an infructescence native of occidental Asia and Mediterranean Europe, popularly referred to as pomegranate. It has been used in ethnomedicine for several applications, including the treatment of obesity, inflammation, diabetes, and the regulation of blood lipid parameters. Thus, pomegranate has been linked to the treatment of cardiovascular diseases that have endothelial dysfunction as a common factor acting mainly against oxidative stress due to its high polyphenol content. Its biocomponents have antihypertensive, antiatherogenic, antihyperglycemic, and anti-inflammatory properties, which promote cardiovascular protection through the improvement of endothelial function. METHODS: Different electronic databases were searched in a non-systematic way to uncover the literature of interest. CONCLUSION: This review article presents updated information on the role of pomegranate in the context of endothelial dysfunction and cardiovascular diseases. We have shown that pomegranate, or rather its components (e.g., tannins, flavonoids, phytoestrogens, anthocyanins, alkaloids, etc.), have beneficial effects on the cardiovascular system, improving parameters such as oxidative stress and the enzymatic antioxidant system, reducing reactive oxygen species formation and acting in an anti-inflammatory way. Thus, this review may contribute to a better understanding of pomegranate's beneficial actions on endothelial function and possibly to the development of strategies associated with conventional treatments of cardiovascular diseases.


Asunto(s)
Lythraceae , Granada (Fruta) , Antioxidantes/farmacología , Asia , Europa (Continente) , Frutas , Humanos , Extractos Vegetales
4.
Toxicon ; 185: 5-14, 2020 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-32569848

RESUMEN

Cardiovascular effects induced by snake venoms, in spite of having a crucial role in the outcome of the envenomation, have been less studied than other toxic activities displayed by these venoms. In this study we evaluated acute cardiovascular responses to Bothrops leucurus venom - Bl-V - both in vivo, in anesthetized rats, and in vitro, in isolated rat mesenteric resistance arteries. Bl-V (10-100 µg protein/kg) caused dose-dependent hypotension, followed by gradual recovery (2-20 min) to basal levels, and induced dose-dependent (1-20 µg/mL) vasodilation in pre-contracted arteries, what was more pronounced when the endothelium remained intact. These effects were partially counteracted by pre-treatment with indomethacin (cyclooxygenase inhibitor). Prior incubation of Bl-V with commercial pentavalent Bothrops antivenom also attenuated the cardiovascular effects induced by the venom, in spite of it not being among the venoms used for the development of the bothropic antivenom. Through an approach based on two chromatographic steps and mass spectrometry (MALDI-ToF and MALDI-ISD), a component with acute cardiovascular effects was isolated and identified as the basic phospholipase blD-PLA2, previously purified from the venom of B. leucurus. Taken together, our results show that, at low doses, the venom of B. leucurus induces transient, acute hypotension in anesthetized rats following systemic vasodilation in a dose-dependent way. In addition, we provide clear evidence of the involvement of the enzymatic activity of blD-PLA2 in this cardiovascular response, acting via the production of vasodilating prostanoids.


Asunto(s)
Bothrops , Venenos de Crotálidos/toxicidad , Fosfolipasas A2/metabolismo , Animales , Hipotensión/inducido químicamente , Ratas , Venenos de Serpiente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA